Advertisement

Related Videos

Opportunities to Optimize Cancer Policies Panel Discussion

Amit Sanyal, MD: A Clinician’s Perspective

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Varsha Gandhi, PhD, on Ibrutinib

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Advertisement

Advertisement




Jun
30
Today In Oncology
I Miss My Life
AACR Cancer Disparities Progress Report Mortality Rates Improve But Care Inequities Persist
Fertility Preservation Access Remains Limited and Unequal for Many Girls and Young Women With Cancer
Adverse Events With CD3-Based T-Cell–Engaging Bispecific Antibody Treatment in Cancer
Survey Results Show Patients Prefer Learning of a Diagnosis From Their Doctor Rather Than a Health Portal
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo